News & Updates
Filter by Specialty:
Week 2 adalimumab levels predict clinical remission in IBD patients
Serum levels of adalimumab at week 2 is associated with short-term clinical remission in patients with inflammatory bowel disease (IBD), a study has shown.
Week 2 adalimumab levels predict clinical remission in IBD patients
23 Sep 2022
Low zinc, vitamin D levels may predict susceptibility to COVID-19
Patients with COVID-19 show very low levels of 25-hydroxyvitamin D and zinc, regardless of age, sex, and comorbidities, reports a study. Vitamin D and zinc deficiency appears to be relevant factors in identifying individuals who are susceptible to SARS-CoV-2 infection.
Low zinc, vitamin D levels may predict susceptibility to COVID-19
23 Sep 2022
Counseling tied to lower 30-day hospital readmission in acute alcoholic pancreatitis
A recent study has found that less than half of patients with alcohol-induced acute pancreatitis (AAP) receive alcohol counseling.
Counseling tied to lower 30-day hospital readmission in acute alcoholic pancreatitis
23 Sep 2022
Rocatinlimab a new treatment option for head and neck AD?
Rocatinlimab improved disease severity in patients with moderate-to-severe head and neck atopic dermatitis (H&N AD), a post hoc analysis of a phase IIb trial has shown.
Rocatinlimab a new treatment option for head and neck AD?
23 Sep 2022
Play-based exercise boosts fitness, fundamental movement in kids with bronchiectasis
Children suffering from bronchiectasis may benefit from a play-based therapeutic exercise regimen, which results in better fitness and fundamental movement skill (FMS), according to a recent pilot trial.
Play-based exercise boosts fitness, fundamental movement in kids with bronchiectasis
23 Sep 2022
Evolocumab safety, efficacy affirmed in Arabic patients
PCSK9 inhibition with evolocumab produces clinically meaningful and sustained reductions in certain lipid parameters in a predominantly Arabic population of individuals with familial hypercholesterolaemia (FH) and other non-FH indications, according to a study.
Evolocumab safety, efficacy affirmed in Arabic patients
23 Sep 2022
DANFLU-1: High-dose quadrivalent flu vax reduces hospitalization, death in older adults
Older adults who receive a high-dose quadrivalent influenza vaccine have a 49 percent reduced risk of death and a 64 percent reduced risk of hospitalization for influenza or pneumonia compared with those who receive a standard-dose vaccine, results of the DANFLU-1 study showed.
DANFLU-1: High-dose quadrivalent flu vax reduces hospitalization, death in older adults
22 Sep 2022
HIIT, resistance training boost wellbeing in chronic lymphocytic leukaemia
Patients with chronic lymphocytic leukaemia (CLL) may benefit from an exercise regimen consisting of high-intensity interval training (HIIT) and resistance training (RT), which could lead to better functional and general wellbeing, as well as a lower burden of lymphoma-specific symptoms, reports a recent study.
HIIT, resistance training boost wellbeing in chronic lymphocytic leukaemia
22 Sep 2022
POP: Delayed intake, missing one pill not a major reason for contraceptive failure
Delayed intake of a progestogen-only pill (POP) or missing one pill does not necessarily reduce its theoretical contraceptive protection, with little effect on cervical mucus and ovulation, as shown in a study.
POP: Delayed intake, missing one pill not a major reason for contraceptive failure
22 Sep 2022
Intensive weight-loss does not improve outcomes in obese NAFLD patients
An intensive weight-loss intervention has failed to substantially improve the treatment outcomes among obese patients with nonalcoholic fatty liver disease (NAFLD), reports a recent study.